Form 4: GE HealthCare CEO, Imaging, Rott Roland, Reports Acquisition of Restricted Stock Units and Employee Stock Options

Roland Rott, CEO, Imaging, of GE HealthCare Technologies Inc., reports the acquisition of restricted stock units and employee stock options.

Summary

• On August 15, 2024, Roland Rott, CEO, Imaging, of GE HealthCare Technologies Inc., acquired 2,784 shares of common stock in the form of restricted stock units.
• These restricted stock units were awarded at a price of $0 per share.
• 33% of these restricted stock units will vest on September 1, 2025, 33% will vest on September 1, 2026, and 34% will vest on September 1, 2027, subject to certain conditions.
• Each restricted stock unit represents the right to receive one share of GE HealthCare common stock at settlement.
• Rott also acquired an employee stock option for 8,419 shares of GE HealthCare common stock with an exercise price of $85.30.
• 33% of the employee stock options will become exercisable on September 1, 2025, 33% will become exercisable on September 1, 2026, and 34% will become exercisable on September 1, 2027, subject to certain conditions.
• The employee stock options expire on August 15, 2034.

Sentiment

Score: 6

Explanation: The sentiment is neutral. It's a standard disclosure of stock and option awards, which is neither particularly positive nor negative on its own. The vesting schedule suggests a long-term incentive, which is mildly positive.

Positives

• The acquisition of restricted stock units and employee stock options suggests a long-term commitment by the CEO, Imaging, to the company's success.

Future Outlook

The vesting schedules for the restricted stock units and employee stock options indicate a multi-year incentive plan for the reporting person.

Industry Context

Form 4 filings are standard disclosures required by the SEC to provide transparency into the transactions of company insiders, allowing investors to track management's alignment with shareholder interests.

Comparison to Industry Standards

• Equity compensation is a common practice in the healthcare industry to incentivize executives.
• Vesting schedules of three to four years are typical for restricted stock units and stock options.
• The specific terms of the awards (number of shares, exercise price, vesting schedule) would need to be compared to peer companies to assess their competitiveness.

Stakeholder Impact

• The stock and option awards align management's interests with those of shareholders, potentially driving long-term value creation.

Key Dates